Clinical Trial Update: Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD) [NA]

View source ↗

Summary

The NOTIFY-ASCVD clinical trial, studying incidental coronary artery calcium in patients with atherosclerotic cardiovascular disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Snippet

Sponsor: Stanford University | Conditions: ASCVD, Coronary Artery Calcification | NA | Status: COMPLETED